Novel hyaluronic acid dermal filler: Dermal gel extra physical properties and clinical outcomes

Dermatologic Surgery

Volumn 36, Issue SUPPL. 3, 2010, Pages 1833-1841

  Monheit, Gary D ^a   Baumann, Leslie S ^b   Gold, Michael H ^c   Goldberg, David J ^d   Goldman, Mitchel P ^e   Narins, Rhoda S ^f   Bachtell, Nathan ^g   Garcia, Emily ^h   Kablik, Jeffrey ^g   Gershkovich, Julia ^g   Burkholder, David ^h  

^a TOTAL   (France)

^b UNIVERSITY OF MIAMI   (United States)

^c Tennessee Clinical Research Center   (United States)

^d Skin Laser and Surgery Specialists of NY/NJ   (United States)

^e Suite 300   (United States)

^f Dermatology Surgery and Laser Center   (United States)

^g GENZYME CORPORATION   (United States)

^h Mentor World Wide LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMAL GEL EXTRA; FILLER; HYALURONIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELASTICITY; ESTHETIC SURGERY; FEMALE; GEL; HUMAN; HUMAN EXPERIMENT; MALE; NASOLABIAL FOLD; NORMAL HUMAN; OUTCOME ASSESSMENT; PAIN; PHYSICAL PARAMETERS; PRIORITY JOURNAL; SCORING SYSTEM; SKINFOLD; WRINKLE;

CROSS-LINKING REAGENTS; FACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; RHYTIDOPLASTY; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VISCOSUPPLEMENTS;

EID: 78349258124     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01780.x     Document Type: Article

References (33)

1. Alam M, Gladstone H, Kramer EM, et al,. ASDS guidelines of care: injectable fillers. Dermatol Surg 2008; 34 (Suppl 1): S115-48.
2. Busso M., Soft tissue augmentation: nonsurgical approaches to treatment of the mid and lower facial regions. Dermatol Nurs 2008; 20: 211-4, 217-9.
3. Carruthers JD, Glogau RG, Blitzer A., Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg 2008; 121: 5S-30S.
4. Cox SE, Finn JC., Social implications of hyperdynamic facial lines and patient satisfaction outcomes. Int Ophthalmol Clin 2005; 45: 13-24.
5. Fagien S, Cox SE, Finn JC, et al,. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytides: a double-blind, randomized, placebo-controlled study. Dermatol Surg 2007; 33: S2-9.
6. Kosowski TR, McCarthy C, Reavey PL, et al,. A systematic review of patient-reported outcome measures after facial cosmetic surgery and/or nonsurgical facial rejuvenation. Plast Reconstr Surg 2009; 123: 1819-27.
7. Cosmetic Surgery National Data Bank Statistics. New York: American Society for Aesthetic Plastic Surgery; 2010.
8. 2010 Report of the 2009 Statistics, National Clearinghouse of Plastic Surgery Statistics. Arlington Heights, IL: American Society of Plastic Surgeons; 2010.
9. Carruthers J, Cohen SR, Joseph JH, et al,. The science and art of dermal fillers for soft-tissue augmentation. J Drugs Dermatol 2009; 8: 335-50.
10. Pinsky MA, Thomas JA, Murphy DK, et al,. Juvederm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness. Aesthet Surg J 2008; 28: 17-23.
11. Narins RS, Brandt FS, Leyden J, et al,. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588-95.
12. Hamilton RG, Strobos J, Adkinson NF Jr., Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic acid particles. Dermatol Surg 2007; 33 (Suppl 2): S176-85.
13. Matarasso SL, Carruthers JD, Jewell ML., Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 2006; 117: 3S-34S.
14. Carruthers JD, Fagien S, Matarasso SL., Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 2004; 114: 1S-22S.
15. Monheit GD, Coleman KM., Hyaluronic acid fillers. Dermatol Ther 2006; 19: 141-50.
16. Kablik J, Monheit GD, Yu L, et al,. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg 2009; 35 (Suppl 1): 302-12.
17. Tezel A, Fredrickson GH., The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 2008; 10: 35-42.
18. Falcone SJ, Berg RA., Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. J Biomed Mater Res A 2008; 87: 264-71.
19. Restylane Injectable Gel [package insert]. Scottsdale, AZ: Medicis Aesthetics Inc., 2008
20. Monheit GD, Gendler EC, Klein AW, et al,. Development and validation of the Genzyme 6-point grading scale in patients undergoing correction of nasolabial folds with Zyplast Collagen Implant. Dermatol Surg 2010, in press.
21. Lemperle G, Holmes RE, Cohen SR, et al,. A classification of facial wrinkles. Plast Reconstr Surg 2001; 108: 1735-50.
22. Gennisson JL, Baldeweck T, Tanter M, et al,. Assessment of elastic parameters of human skin using dynamic elastography. IEEE Trans Ultrason Ferroelectr Freq Control 2004; 51: 980-9.
23. Monheit GD, Campbell R, Neugent H, et al,. Reduced pain with the use of proprietary hyaluronic acid for correction of nasolabial folds: a patient-blinded, prospective, randomized controlled trial. Dermatol Surg 2010; 36: 94-101.
24. Weinkle SH, Bank DE, Boyd CM, et al,. A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvederm injectable gel with and without lidocaine. J Cosmet Dermatol 2009; 8: 205-10.
25. Restylane-L Injectable Gel with 0.3% Lidocaine [package insert]. Scottsdale, AZ: Medicis Aesthetics, Inc., 2010
26. Perlane-L Injectable Gel with 0.3% Lidocaine [package insert]. Scottsdale, AZ: Medicis Aesthetics, Inc., 2010
27. Juvederm Ultra XC [Prescribing Information]. Santa Barbara, CA: Allergan, Inc., 2010
28. Juvederm Ultra Plus XC [Prescribing Information]. Santa Barbara, CA: Allergan, Inc., 2010
29. Juvederm Ultra [Prescribing Information]. Santa Barbara, CA: Allergan, Inc., 2008
30. Juvederm Ultra Plus [Prescribing Information]. Santa Barbara, CA: Allergan, Inc., 2008
31. Prevelle SILK [Prescribing Information]. Santa Barbara, CA: Mentor Corporation, 2008
32. Elevess [Prescribing Information]. San Diego, CA: Anika Therapeutics, Inc., 2008
33. Narins RS, Dayan SH, Brandt FS, et al,. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008; 34 (Suppl 1): S2-8.